NCT01021020View on ClinicalTrials.gov

Bioequivalence Study of Colchicine Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
Healthy
Interventions
DRUG

Colchicine

0.6mg tablet administered after a fast of at least 10 hours

DRUG

Colchicine

0.6mg tablet administered after a standardized high-fat, high-calorie breakfast

DRUG

Colchicine/Probenecid

0.5mg/500mg tablet administered after a fast of at least 10 hours

Trial Locations (1)

58104

PRACS Institute, Ltd. - Cetero Research, Fargo

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT01021020 - Bioequivalence Study of Colchicine Tablets | Biotech Hunter | Biotech Hunter